Traumatic brain injury (TBI) occurs when trauma disrupts normal brain functions, potentially causing severe physical, cognitive, and emotional impairments. Researchers are exploring stem cells as a possible treatment because these cells might...
Recent clinical data presented at the AAOS 2025 Annual Meeting in San Diego suggest that MEDIPOST's stem cell therapy, Cartistem, may offer a more effective treatment for severe knee osteoarthritis (OA) compared...
Following Utah's bills allowing clinics to offer umbilical stem cell therapy in 2024, Florida looks to do the same. The two bills, SB 1768 and HB 1617 were introduced by Republican representatives...
Celularity Inc. (Nasdaq: CELU), a regenerative and cellular medicine company, announced that it received recommendation letters from the FDA's Tissue Reference Group (TRG), regarding its Natalin and Acelagraft™ products confirming that each product “appears...
South Korea's MEDIPOST, Inc., a company developing stem cell-based therapeutics, has announced the appointment of five senior executives, which they say will bring decades of expertise in biologics and cell & gene...
